Latest

09:02
【SIMCERE PHARMA(02096.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 828.72 million, YoY increase of 37.88%】NewTimeSpace News: August 20, 2026, SIMCERE PHARMA(02096.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 4.58 billion, increased by 27.76% YoY.
Tag： SIMCERE PHARMA02096.HKprofit growth
09:02
【JLMAG(06680.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 462.24 million, YoY increase of 51.58%】NewTimeSpace News: August 20, 2026, JLMAG(06680.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 4.65 billion, increased by 32.57% YoY.
Tag： JLMAG06680.HKprofit growth
09:02
【BLUE MOON GROUP(06993.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of HKD 192.47 million, loss narrowed by 55.79% YoY】NewTimeSpace News: August 20, 2026, BLUE MOON GROUP(06993.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 2.88 billion, decreased by 5.07% YoY.
Tag： BLUE MOON GROUP06993.HKloss narrowed
09:02
【LIULIUMEI(06658.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 140.87 million, YoY increase of 33.46%】NewTimeSpace News: August 20, 2026, LIULIUMEI(06658.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 1.06 billion, increased by 10.63% YoY.
Tag： Liuliumei06658.HKprofit growth
08:23
【HYBRID KINETIC (01188.HK): enters into MOU with Hengwan New Energy on 5 GWh energy storage and power battery project】NewTimeSpace News: On 20 August 2026, HYBRID KINETIC (01188.HK) voluntarily announced that it has entered into an MOU with Hengwan New Energy (Qianshan) Co., Ltd., intending to cooperate on advancing a 5 GWh per annum energy storage and power battery industrial project and jointly developing energy storage cells and power lithium-ion batteries; the cooperation remains indicative in nature and subject to legally binding definitive agreements.
Tag： HYBRID KINETIC01188.HKstrategic cooperation
08:21
【LUYE PHARMA (02186.HK): therapeutic mRNA vaccine LY01620 to initiate Phase II clinical trial in China, HPV viral clearance rate nearly 90%】NewTimeSpace News: On 20 August 2026, LUYE PHARMA (02186.HK) voluntarily announced that its therapeutic mRNA vaccine LY01620 is about to initiate a Phase II clinical trial in China for patients with HPV16-positive HSIL; the Phase I study showed an HPV viral clearance rate of nearly 90% and histological improvement approaching standard surgical levels, with the treatment being non-invasive and not affecting fertility.
Tag： LUYE PHARMA02186.HKClinical Progress
08:19
【HANKING GOLD (03788.HK): Wang Ping appointed Senior Independent Non-Executive Director】NewTimeSpace News: On 20 August 2026, HANKING GOLD (03788.HK) announced that Independent Non-Executive Director Wang Ping has been appointed as Senior Independent Non-Executive Director, effective 20 August 2026, primarily to facilitate communication among independent directors and with shareholders, especially minority shareholders; the position was introduced by reference to the amended Corporate Governance Code.
Tag： HANKING GOLD03788.HKBoard Change
08:16
【SIMCERE PHARMA (02096.HK): Zhu Da appointed Joint Company Secretary succeeding Wan Yushan, waiver granted from company secretary qualification requirements】NewTimeSpace News: On 21 August 2026, SIMCERE PHARMA (02096.HK) announced that Wan Yushan has ceased as Joint Company Secretary (remaining ED and CFO), with Board Secretary Zhu Da appointed in addition as his successor and granted a three-year waiver from company secretary qualification requirements (assisted by Mai Baowen); Mr. Zhu has over 12 years of investment banking and corporate management experience.
Tag： SIMCERE PHARMA02096.HKBoard Change
08:12
【XIN YUAN ENT (01748.HK): resumption proposal submitted, shares remain suspended】NewTimeSpace News: On 21 August 2026, XIN YUAN ENT (01748.HK) announced that it submitted a resumption proposal to the Stock Exchange on 14 August 2026, with the forensic investigation and internal control review reports issued and all financial results published; the shares remain suspended since 21 February 2025 until the resumption guidance is fulfilled.
Tag： XIN YUAN ENT01748.HKSuspension
08:10
【CSTONE PHARMA-B (02616.HK): IND of CS5007 (EGFR/HER3 bispecific ADC) approved by NMPA, fast-tracked in 23 working days】NewTimeSpace News: On 21 August 2026, CSTONE PHARMA-B (02616.HK) voluntarily announced that the IND of CS5007, an EGFR/HER3 bispecific ADC, has been fast-tracked and approved by the NMPA in 23 working days; its global multi-center Phase I trial was initiated in Australia in June 2026 with the first patient enrolled, and approximately 310 patients are expected to be enrolled.
Tag： CSTONE PHARMA-B02616.HKClinical Trial
08:08
【LONGBIO-B (01779.HK): BLA of LP-003 for seasonal allergic rhinitis accepted by NMPA】NewTimeSpace News: On 21 August 2026, LONGBIO-B (01779.HK) voluntarily announced that the BLA of LP-003 for seasonal allergic rhinitis has been accepted by the NMPA; LP-003 is a novel anti-IgE antibody targeting multiple allergic diseases, and its IND application for peanut allergy was previously approved by the US FDA.
Tag： LongBio-B01779.HKClinical Progress
07:57
【Medcaptain Medical Technology: passes HKEX hearing on 20 August, No.1 in infusion workstation for 8 consecutive years】NewTimeSpace News: On 20 August 2026, Medcaptain Medical Technology passed the HKEX listing hearing, with Morgan Stanley and Huatai International as joint sponsors; the Company is a global medical device provider covering life support, minimally invasive intervention and in vitro diagnostics, ranking first in China's infusion workstation market from 2018 to 2025, and turned profitable in 2025 with a net profit of RMB 50.7 million.
Tag： MedcaptainIPOpass the listing hearing
07:50
【PANACRO refiles for Hong Kong listing on 20 August, digital-enabled clinical CRO】NewTimeSpace News: On 20 August 2026, PANACRO (Hangzhou) Pharmaceutical Consulting Co., Ltd. refiled for a Hong Kong listing, with China Industrial Securities International and ICBC International as joint sponsors; the Company is a clinical CRO headquartered in Hangzhou, ranking 14th among Chinese companies by 2025 clinical CRO service revenue (0.7% share), with digital systems shortening bid preparation time by approximately 30% and a gross margin of 38.9% above industry average.
Tag： PANACROIPOfile a listing application
22:05
【EMPEROR INT'L (00163.HK): Sells Macau Property for HKD 106 Million, Constituting a Discloseable Transaction】NewTimeSpace News: On 20 August 2026, EMPEROR INT'L (00163.HK) agreed to sell a five-commercial-unit property of 15,788 square feet on San Ma Lo, Macau for HKD 106 million, with a deposit of HKD 20 million already paid and the balance of HKD 86 million payable upon completion, expecting to record a fair value loss of approximately HKD 14 million.
Tag： EMPEROR INTL00163.HKProperty Disposal
22:03
【ENVISION GREEN (01783.HK): Completes Placing of Existing Shares and Top-Up Subscription at HKD 4.66 per Share; Completes Subscription of RMB 472 Million Convertible Bonds】NewTimeSpace News: On 20 August 2026, ENVISION GREEN (01783.HK) completed a placing of 117.9 million shares and a top-up subscription at HKD 4.66 per share, and completed the subscription of RMB 472 million convertible bonds bearing 5.00% interest per annum; combined net proceeds were approximately HKD 1,077.68 million, of which approximately 90% will fund the cloud computing and data centre acquisition and the AI server purchase.
Tag： ENVISION GREEN01783.HKPlacing
21:58
【ZGC TEC LEASING (01601.HK): Subscribes 49.5% Stake in RMB 415 Million Venture Fund, Constituting Discloseable and Connected Transaction】NewTimeSpace News: On 20 August 2026, ZGC TEC LEASING (01601.HK) participated in establishing a venture fund with registered capital of RMB 415 million, subscribing for 49.5% of its committed capital; the transaction, involving connected person Zhongguancun Xietong, constitutes a discloseable and connected transaction subject to independent shareholders' approval.
Tag： ZGC TEC LEASING01601.HKDiscloseable and Connected Transaction
21:55
【AIDIGONG (00286.HK): Trading Remains Suspended; 18-Month Delisting Deadline Expired and Extension Sought】NewTimeSpace News: On 20 August 2026, AIDIGONG (00286.HK) provided a quarterly update on its resumption progress; the 18-month delisting deadline expired the same day and an extension has been sought, the company has still not received financial information from Shenzhen AIDIGONG and remains non-compliant with several Listing Rules requirements, with trading suspended since 21 February 2025.
Tag： AIDIGONG00286.HKTrading Suspension
21:53
【NOVATECH INTEL (08131.HK): Zhou Weixing Resigns as Independent Non-Executive Director; Zhang Jinping Appointed Executive Director and Chief Executive Officer; Wang Yaping Appointed Executive Director】NewTimeSpace News: On 20 August 2026, NOVATECH INTEL (08131.HK) announced that Ms. Zhang Jinping was appointed executive director and chief executive officer, Ms. Wang Yaping was appointed executive director, Mr. Zhou Weixing resigned as independent non-executive director, and Ms. Li Jing succeeded as independent non-executive director and chair of the three committees.
Tag： NOVATECH INTEL08131.HKPersonnel Change
21:37
【BJENERGY INTL (00686.HK): Jingneng Smart Energy Signs Comprehensive Energy Project Agreement with Beijing University of Technology, Total Investment of RMB 236.17 Million】NewTimeSpace News: On 20 August 2026, BJENERGY INTL (00686.HK) disclosed that Jingneng Smart Energy entered a comprehensive energy project agreement with Beijing University of Technology, with total construction investment of RMB 236.17 million and a 20-year operation period, constituting a discloseable transaction.
Tag： BJENERGY INTL00686.HKDiscloseable Transaction
21:35
【51WORLD (06651.HK): Establishes Joint Venture with Shenzhen Union Vision, Launches Embodied AI Data Platform AperData】NewTimeSpace News: On 20 August 2026, 51WORLD (06651.HK) established a joint venture with Shenzhen Union Vision and launched the embodied AI data platform AperData, which has received over 10,000 orders with first deliveries at the end of August 2026; the establishment does not constitute a notifiable transaction.
Tag： 51WORLD06651.HKstrategic cooperation
Previous1..4950 515253..491     491 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments